Dr. Lal Path Labs Ltd. — Others, 09-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Dr. Lal PathLabs has announced a board meeting to consider the financial results for the quarter and half-year. The company’s registrar and share transfer agent, MUFG Intime India, confirmed that no demat requests were received during the quarter, indicating no changes in shareholding through dematerialization. Notably, the company holds no physical shares, reflecting full dematerialization. This update reassures shareholders about streamlined shareholding and ongoing compliance in share management.